| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| ibritumomab | leukocyte surface antigen leu-16 | NA | Successful target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Lymphoma Non-Hodgkin[MeSHID:D008228] Malignant lymphoma lymphocytic intermediate differentiation diffuse[MeSHID:D020522] |
14.14 | approved | unknown |
| click here to return to the previous page | ||||||||